Glaucocalyxin A delays the progression of OA by inhibiting NF- κB and MAPK signaling pathways
Osteoarthritis (OA) is a common degenerative joint condition marked by inflammation and cartilage breakdown. Currently, there is a dearth of treatment medications that can clearly slow the course of OA. Glauco...
Source: Journal of Orthopaedic Surgery and Research - Category: Orthopaedics Authors: Xin Hong, Xuqiang Liu, Bo Li, Shoujie Shi, Kai Xiao, Tiantian Xu, Yaoyang Nie, Min Dai and Meisong Zhu Tags: Research article Source Type: research
More News: Orthopaedics | Osteoarthritis